SAB Biotherapeutics, Inc. · Brief

Next report

12 days

Nov 13 · before openest.Q3 FY26

Expected move

No implied move.

No reported quarters.

Nov 13 report · est.

Bull2

87managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+1.06%change in shares held by the ten largest reporting managers13F · Jun 30 '26

Bear2

8 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

14managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

SABS report session

No linked exposure.

Oct 30impliedImplied move: ±64.7% into Nov 13 earnings (Oct 30 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.